Nissan Ran, Cohen Rana, Hurgin Maria, Popilski Hen, Zahalka Khaleel, Natan Meirav Ben, Schwartzberg Eyal
Pharmaceutical Society of Israel, Tel Aviv, Israel.
Division of Clinical Pharmacy, Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem, Israel.
Isr J Health Policy Res. 2025 May 1;14(1):26. doi: 10.1186/s13584-025-00686-4.
Telepharmacy, the use of telecommunications technology to facilitate pharmacy services, has emerged as an integral component of telehealth, particularly during the COVID-19 pandemic. In Israel, the shortage of pharmacists nationwide has led to longer wait times and reduced consultation opportunities at community pharmacies. In response, the Pharmaceutical Society of Israel (PSI) established a telepharmacy call center to provide free pharmaceutical consultations to the public. This study aimed to describe the framework of this center, the types of pharmaceutical consultations and patient satisfaction with the service.
This cross-sectional observational study analyzed unidentified data from 1,542 ambulatory patient inquiries to the PSI telepharmacy call center between October 2022 and June 2023. The consultations were categorized into clinical, logistical, and patient rights-related inquiries. A satisfaction survey was conducted among a representative sample of callers.
The majority of inquiries (93.3%) were received via telephone, with the 65-85 age group accounting for 38.4% of callers. A small proportion of inquiries were submitted via email, either exclusively or in combination with a telephone communication. Clinical inquiries comprised 89% of the total, with the most common topics being drug interactions (26.7%), general drug usage guidance (17.8%), and inquiries about drug side effects (16.4%). The patient satisfaction survey revealed that 87% of respondents strongly agreed that the pharmacists demonstrated empathy and attentiveness, and 93.5% were satisfied with the responses provided. The overall service rating was 8.9 out of 10, and 94.1% of respondents were willing to recommend the call center to others.
This study highlights the value and feasibility of operating a national telepharmacy call center in Israel, addressing the diverse pharmaceutical needs of the public, particularly the elderly population. The high satisfaction levels among callers underscore the potential for such initiatives to enhance access to comprehensive pharmaceutical consultation and improve medication management.
远程药学,即利用电信技术促进药学服务,已成为远程医疗的一个重要组成部分,尤其是在新冠疫情期间。在以色列,全国范围内药剂师短缺导致社区药房的等待时间延长,咨询机会减少。作为回应,以色列药学会(PSI)设立了一个远程药学呼叫中心,为公众提供免费的药学咨询服务。本研究旨在描述该中心的框架、药学咨询的类型以及患者对该服务的满意度。
这项横断面观察性研究分析了2022年10月至2023年6月期间向PSI远程药学呼叫中心咨询的1542名门诊患者的匿名数据。咨询被分为临床、后勤和患者权利相关咨询。对有代表性的来电者样本进行了满意度调查。
大多数咨询(93.3%)通过电话接收,65 - 85岁年龄组占来电者的38.4%。一小部分咨询通过电子邮件单独提交或与电话沟通相结合提交。临床咨询占总数的89%,最常见的主题是药物相互作用(26.7%)、一般药物使用指导(17.8%)以及药物副作用咨询(16.4%)。患者满意度调查显示,87%的受访者强烈同意药剂师表现出同理心和关注度,93.5%的人对提供的回复感到满意。总体服务评分为8.9分(满分10分),94.1%的受访者愿意向他人推荐该呼叫中心。
本研究强调了在以色列运营全国性远程药学呼叫中心的价值和可行性,满足了公众尤其是老年人群体多样化的药学需求。来电者的高满意度凸显了此类举措在增加获得全面药学咨询机会和改善药物管理方面的潜力。